If President Bush hoped that his decision last week to permit limited federal funding of embryonic stem-cell research would quiet the ferocious debate surrounding the issue, it was a hope that was quickly dashed. Since his announcement, advocates on both sides have continued to find plenty to argue about--whether there are really 60 existing cell lines on which the President would allow research; whether those lines would be sufficient to yield real results; whether the restrictive rules will simply drive U.S. stem-cell researchers to other countries where they can do their work with less government interference.
But nearly everyone agrees on...